Sunday, January 17, 2021

Med, Biotech & Pharma

Emerging Growth Medical, Biotechnology and Pharmaceutical Companies

This Emerging Growth Biotech to Showcase Its Stuff

On Friday, shares broke resistance on record dollar volume which makes perfect sense as there are over 2 million equine owners in the US, many of which pay attention to this convention.

Cracking the FDA Code to COVID-19 Approvals

100% correlation between this list and an EUA approval5 drug candidates on the list have not received an EUA3 drug candidates seem imminent What this...

Halberd Corp. (HALB) Research Yields Promising SARS-CoV-2 Antibody in Laboratory Testing

Halberd Corp. (HALB) Research Yields Promising SARS-CoV-2 Antibody in Laboratory Testing

AXIM Biotechnologies (AXIM) Develops ELISA-Based Neutralizing Antibody Diagnostic Test for COVID-19 and Applies for...

AXIM Biotechnologies (AXIM) Develops ELISA-Based Neutralizing Antibody Diagnostic Test for COVID-19 and Applies for Patent; Company’s Fourth COVID-19 Test-Focused Patent Application

Medicevo (COUV) Unveils Graphene Face Mask Which Filters 98% Of COVID-19 Particles

Medicevo (COUV) Unveils Graphene Face Mask Which Filters 98% Of COVID-19 Particles

Innovation Pharmaceuticals (IPIX) COVID-19 Clinical Trial to Support Additional Development of Brilacidin as a...

Innovation Pharmaceuticals (IPIX) COVID-19 Clinical Trial to Support Additional Development of Brilacidin as a “Pan-Coronavirus” Therapeutic

Is this Small Cap Biotech going to Uplist to NASDAQ?

Should it be a surprise that we learned just last week in the company’s 8-K that PetVivo Holdings, Inc. (OTCQB: PETV) adopted and approved an amended and restated “Charter of the Audit Committee”, “Charter of the Compensation Committee” and a “Nominating and Corporate Governance Committee Charter?” All of which are required by NASDAQ.

Rapid Countermeasure Against COVID-19: Therapeutics Not Vaccines

In the interim, no patients can get the drug via emergency IND because the FDA has stopped that access. This is a point of moral outrage. By not looking at the interim data for leronlimab in an urgent fashion the FDA is condemning thousands of people to death daily.

Innovation Pharmaceuticals (IPIX) Announces Overseas Regulatory Filing Submitted For COVID-19 Clinical Study

Innovation Pharmaceuticals (IPIX) Announces Overseas Regulatory Filing Submitted For COVID-19 Clinical Study

This Niche Biotech Company is paving the way with a Sponsored Research Agreement

There is a niche biotech company called PetVivo, Holdings, Inc. (OTCQB: PETV). They are an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets. PetVivo is benefiting from trials on the human side with a lower barrier to approval for pets.

Latest News

Stocks involved in Covid-19 Testing could be the all out Winners

Another solid player in the COVID-19 test kit market is Avalon GloboCare (NASDAQ: AVCO) who recently partnered with Adial Pharmaceuticals (NASDAQ: ADIL) announcing a Strategic Collaboration for Global Distribution of COVID-19 Point-of-Care Antibody Rapid Test Devices

Hydrogen Stocks, The New EV